Cargando…
Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights
Several lines of evidence have shown that the endogenous cannabinoids are implicated in several neuropsychiatric diseases. Notably, preclinical and human clinical studies have shown a pivotal role of the cannabinoid system in nicotine addiction. The CB(1) receptor inverse agonist/antagonist rimonaba...
Autores principales: | Gamaleddin, Islam Hany, Trigo, Jose M., Gueye, Aliou B., Zvonok, Alexander, Makriyannis, Alexandros, Goldberg, Steven R., Le Foll, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373509/ https://www.ncbi.nlm.nih.gov/pubmed/25859226 http://dx.doi.org/10.3389/fpsyt.2015.00041 |
Ejemplares similares
-
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012) -
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling
por: Gueye, Aliou B., et al.
Publicado: (2016) -
Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor
por: Mallipeddi, Srikrishnan, et al.
Publicado: (2018) -
The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
por: Gueye, Aliou B., et al.
Publicado: (2016) -
The Role of Cannabinoid Transmission in Emotional Memory Formation: Implications for Addiction and Schizophrenia
por: Tan, Huibing, et al.
Publicado: (2014)